Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-07

Clinical Trial Update: Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion [Phase 4]

View source ↗

Summary

Phase 4 trial update on preoperative transarterial chemoembolization for resectable hepatocellular carcinoma with portal vein tumor thrombus (PVTT).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sun Yat-sen University | Conditions: Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus | Phase 4 | Status: COMPLETED